The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mcintyre David since 2009.
The trader's CIK number is 1404254.
At the time of the last reporting, Mcintyre David was the CFO & COO of Avita Therapeutics, Inc.. (stock ticker symbol RCEL).
Also see all insider trading activities at Avita Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | HTWR | 0 | $0 | 37,486 | $2,299,603 | 35,863 | $219,474 |
| 2010 | HTWR | 0 | $0 | 60,030 | $3,395,250 | 60,030 | $702,018 |
| 2009 | HTWR | 0 | $0 | 12,992 | $405,832 | 10,916 | $242,482 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | RCEL | 693 | $16,076 | 0 | $0 | 0 | $0 |
2. Avita Therapeutics, Inc. (RCEL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-12-19 | HTWR | Option Ex | 5,714 | 38.41 | 219,474 |
| 2011-12-20 | HTWR | Option Ex | 3,125 | .00 | 0 |
| 2011-12-19 | HTWR | Sale | 7,337 | 68.71 | 504,125 |
| 2011-12-20 | HTWR | Sale | 3,125 | 68.44 | 213,890 |
| 2011-09-16 | HTWR | Option Ex | 24,167 | .00 | 0 |
| 2011-09-19 | HTWR | Sale | 16,168 | 54.90 | 887,542 |
| 2011-09-16 | HTWR | Sale | 7,999 | 55.44 | 443,488 |
| 2011-02-22 | HTWR | Option Ex | 2,857 | .00 | 0 |
| 2011-02-22 | HTWR | Sale | 2,857 | 87.70 | 250,558 |
| 2010-09-17 | HTWR | Sale | 11,602 | 71.36 | 827,918 |
| 2010-09-16 | HTWR | Sale | 12,565 | 71.42 | 897,329 |
| 2010-09-16 | HTWR | Option Ex | 24,167 | .00 | 0 |
| 2010-04-29 | HTWR | Option Ex | 8,624 | 24.19 | 208,614 |
| 2010-04-30 | HTWR | Option Ex | 10,210 | 24.33 | 248,409 |
| 2010-04-28 | HTWR | Option Ex | 3,000 | 24.19 | 72,570 |
| 2010-04-30 | HTWR | Sale | 10,210 | 54.30 | 554,403 |
| 2010-04-29 | HTWR | Sale | 8,624 | 49.97 | 430,941 |
| 2010-04-28 | HTWR | Sale | 3,000 | 50.08 | 150,240 |
| 2010-03-08 | HTWR | Sale | 4,900 | 38.50 | 188,650 |
| 2010-03-09 | HTWR | Sale | 371 | 38.46 | 14,268 |
| 2010-02-25 | HTWR | Sale | 3,300 | 39.32 | 129,756 |
| 2010-02-22 | HTWR | Option Ex | 8,571 | .00 | 0 |
| 2010-01-28 | HTWR | Option Ex | 4,967 | 31.54 | 156,659 |
| 2010-01-28 | HTWR | Sale | 4,967 | 36.85 | 183,033 |
| 2010-01-20 | HTWR | Option Ex | 491 | 32.11 | 15,766 |
| 2010-01-20 | HTWR | Sale | 491 | 38.11 | 18,712 |
| 2009-12-07 | HTWR | Option Ex | 330 | 24.03 | 7,929 |
| 2009-12-07 | HTWR | Sale | 330 | 32.10 | 10,593 |
| 2009-12-04 | HTWR | Sale | 2,191 | 31.91 | 69,914 |
| 2009-12-04 | HTWR | Option Ex | 2,191 | 24.25 | 53,131 |
| 2009-12-03 | HTWR | Sale | 800 | 31.74 | 25,392 |
| 2009-12-02 | HTWR | Sale | 600 | 31.52 | 18,912 |
| 2009-12-03 | HTWR | Option Ex | 800 | 24.38 | 19,504 |
| 2009-12-01 | HTWR | Sale | 180 | 31.50 | 5,670 |
| 2009-12-02 | HTWR | Option Ex | 600 | 24.33 | 14,597 |
| 2009-12-01 | HTWR | Option Ex | 180 | 23.98 | 4,316 |
| 2009-11-25 | HTWR | Option Ex | 2,200 | 21.87 | 48,114 |
| 2009-11-30 | HTWR | Sale | 1,200 | 31.36 | 37,632 |
| 2009-11-30 | HTWR | Option Ex | 1,200 | 24.09 | 28,908 |
| 2009-11-25 | HTWR | Sale | 2,200 | 32.41 | 71,301 |
| 2009-11-24 | HTWR | Sale | 408 | 32.01 | 13,060 |
| 2009-11-23 | HTWR | Sale | 2,007 | 31.97 | 64,163 |
| 2009-11-24 | HTWR | Option Ex | 408 | 19.36 | 7,898 |
| 2009-11-23 | HTWR | Option Ex | 2,007 | 19.31 | 38,755 |
| 2009-11-20 | HTWR | Sale | 1,000 | 32.76 | 32,759 |
| 2009-11-20 | HTWR | Option Ex | 1,000 | 19.33 | 19,330 |
| 2009-11-16 | HTWR | Sale | 1,000 | 32.13 | 32,130 |
| 2009-07-17 | HTWR | Sale | 1,076 | 22.59 | 24,306 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-16 | RCEL | Buy | 300 | 23.85 | 7,155 |
| 2020-07-17 | RCEL | Buy | 393 | 22.70 | 8,921 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcintyre David (CFO & COO of Avita Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.